Upgrade to SI Premium - Free Trial

Travere Therapeutics (TVTX) PT Raised to $62 at Stifel

August 5, 2026 8:25 AM
(Updated - August 5, 2026 11:14 AM EDT)

Stifel analyst Alex Thompson raised the price target on Travere Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change